LR BV100 Phase 3 in Ventilator Associated Bacterial Pneumonia initiated with first country submission completed and first patients to be dosed in the coming months – Phase 3 read-out expected in H2 ...

Robex and Predictive Discovery have agreed to revised terms under the amended arrangement agreement. Robex Shareholders will receive 7.862 Predictive Shares for each Robex Share, resulting in Robex ...

Featured In Networknewsaudio APR On Urgent Need For Rare Disease Therapies. Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company developing treatments for rare diseases, is highlighted in ...

Growing Momentum Signals Opportunity As Explorers Shift Toward Production, Reveal Substantial Value. This article has been disseminated on behalf of LaFleur Minerals Inc. and may include a paid ...